During the past decade, Regionshospitalet Herning conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Regionshospitalet Herning" #1 sponsor was "Pfizer" with 2 trials, followed by "Bayer" with 1 trials sponsored, "Biotronik SE & Co. KG" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "Claus Anders Bertelsen, PhD, MD" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regionshospitalet Herning" #1 collaborator was "Aalborg University Hospital" with 1 trials as a collaborator, "Aarhus University Hospital" with 1 trials as a collaborator, "Herning Hospital" with 1 trials as a collaborator, "Hillerod Hospital, Denmark" with 1 trials as a collaborator and "Hvidovre University Hospital" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Regionshospitalet Herning" are "Cardiovascular Disease" (2 trials), "Adverse Reaction to Oxytocin" (1 trials), "Analgesia" (1 trials), "Bradyarrhythmia" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Regionshospitalet Herning" in a lesser frequency.

Most popular intervention types in "Regionshospitalet Herning" are "Drug" (8 trials), "Device" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "bococizumab (PF-04950615)" (2 trials), "Abemaciclib" (1 trials), "Active drug" (1 trials) and "BAY2327949" (1 trials). Other intervention names were less common.

The vast majority of trials in "Regionshospitalet Herning" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Regionshospitalet Herning". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Regionshospitalet Herning, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Regionshospitalet Herning, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".